TAAA: Better Outcomes with Renal Fenestration

Courtesy of Dr. Carlos Fava.

 

Better Outcomes with Renal FenestrationThoraco-abdominal aneurysms (TAAA) are a real challenge for surgeons. So far, endovascular repair have rendered good results in these aneurysms, but branch occlusion continues to be their Achilles’ heel”.

 

449 patients were analyzed, 235 (52%) were treated with branched devices (BEVAR) and 214 (48%) with fenestrated devices (FEVAR). Endoprosthesis were Cook Medical.

 

Mean age in both groups was 70, and except for more men and more smokers in the FEVAR group, there were no significant differences between them.

 

856 vessels were revascularized, 445 by BEVAR and 411 by FEVAR. Technical success was 95% with BEVAR and 99% with FEVAR (p=0.01), during the first 24 hours; those receiving BEVAR presented 2% renal occlusion and 2.1% mortality.

 

Follow up was at 20 months; reintervention rate was similar in both groups (4.7% vs. 5.2%) but renal branch occlusion was higher with BEVAR (9.6% vs. 2.3%; p<0.01).

 

At two years, freedom from renal occlusion was higher with FEVAR (90.4% vs. 97.1%; p<0.01) with no difference in global renal function, but renal occlusion rate was higher following BEVAR.

 

Mortality after ruptured aneurysm was six for each group and survival rate at two years was similar (73.4% vs. 80.9%).

 

Conclusion

At med-term follow up, renal evolution with endoprosthesis in toraco-abdominal aneurysms is satisfactory. Fenestrated devices are associated with lower renal occlusion, compared to branched prosthesis.

 

Editorial Comment

These strategies have solved a great problem for surgery, and show good results in different series.

 

Even though the FEVAR prosthesis have shown fairly better performance in different series, they are tailored specifically to each patient’s anatomy, and are therefore more expensive.

 

Eventually, the development of better devices and 3D printers will make this great challenge easier for interventionists.

 

Original Title: Mid-Term Outcomes of Renal Branches Versus Renal Fenestrations for Thoraco-abdominal Aneurysm Repair.

Reference: T. Martín Gonzalez. Eur J Vasc. Endovasc Surg 2016;52:141-148

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

We value your opinion. You can leave your comments, thoughts, questions or suggestions here below.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....